Neoventa Medical has won the prestigious Better World Developer Award 2018.
The award has been established to draw attention to companies or organizations that through innovative product development contribute to a better world. The company behind the award is TogetherTech, a technical consulting company that provides services and competence through the whole process, from idéas to market ready products.
“Our vision is to develop future products for a better world and we hope that the Better World Developer Award …
Neoventa – Better World Developer 2018
A pilot exploratory investigation on pregnant women’s views regarding STan fetal monitoring technology.
A clear communication between maternity care providers and women about technology use in intrapartum care is of great value. This research is now being used to inform the implementation of the first properly powered Australian randomised trial comparing ST Analysis and CTG monitoring.
Read moreExplore the new STAN!
Please visit us at the 3rd European Congress on Intrapartum Care (ECIC) at Karolinska Institutet, 25-27 May in Stockholm
The ECIC congress gives you a unique opportunity for all healthcare professionals working in the labor ward to meet each other and is strongly focused on evidence-based practice and aims to support excellence in all aspects of labour management.
Please come and see us in our booth where we, for the first time, will present our new STAN!
Booth no: 15 & 16
We …
Fetal Electrocardiograph (ST-Analyser or STAN) for intrapartum fetal heart rate monitoring: a friend or a foe?
Chandraharan E
1.a Labour Ward Lead Consultant and Lead for Clinical Governance , St. George’s University Hospitals NHS Foundation Trust, St George’s University of London, London, UK.
Abstract
Cardiotocograph (CTG) is associated with a high false positive rate of up to 60% which may increase the risk of unnecessary intrapartum interventions (emergency caesarean sections or operative vaginal deliveries) without any significant benefits. A recent study on variation of caesarean section rates in England has concluded that there was a very …
Swedish study investigates discrepancies between CTG classification systems, and the impact on ST event significance.
The STAN Clinical Guidelines classification system of cardiotocography (CTG) [1] is originally based on the FIGO classification system from 1987 [2]. In October 2015, the FIGO Intrapartum Fetal Monitoring Expert Consensus Panel presented their new CTG intrapartum classification system (FIGO2015) [3] (Table 1).
Table 1. The FIGO2015 intrapartum cardiotocography (CTG) classification system [3] in summary.
*) Decelerations are repetitive if they occur at >50% of uterine contractions.
a) Accelerations (amplitude >15 bpm, lasting >15 s …
Why was a meta-analysis performed with primary endpoints considered clinically unimportant?
Letter to the Editor accepted in AOGS regarding the latest Meta Analysis:
Why did the authors perform a meta-analysis of studies with primary endpoints they consider clinically unimportant?
Kessler et al. 2016
DOI: 10.1111/aogs.12876
ABSTRACT
The meta-analysis of Blix et al. on ST waveform analysis (STAN) (1) confirmed the results of a previous meta-analysis (2). Their conclusions, however, are based on presuppositions that are highly questionable. The systematic review by Blix et al. (1) was prompted by a recently published American RCT …
Belittling of a significant decline in neonatal metabolic acidosis rate achieved by STAN monitoring
Letter to the Editor accepted in AOGS regarding the latest Meta Analyses:
Belittling of a significant decline in neonatal metabolic acidosis rate achieved by STAN monitoring
Per Olofsson1,2,
DOI: 10.1111/aogs.12861
Abstract:
Blix et al. found in a recent meta-analysis (MA) that intrapartum fetal surveillance with ECG ST analysis (STAN) results in a significant 36% decrease in metabolic acidosis at birth compared to cardiotocography (CTG) alone (1). This demonstrates that STAN monitoring could better than CTG alone protect against hypoxia proceeding to metabolic …
Comments on Blix et al. ST waveform analysis vs. cardiotocography alone
Some topics in obstetrics are more hot than others and we are in the remarkable situation that there are now more meta-analyses (MAs) than randomized controlled trials (RCTs) on the evidence for using fetal ECG ST analysis for fetal surveillance in labor. Previously six MAs (Neilson, 2012; Becker et al., 2012; Potti & Berghella, 2012; Salmelin et al., 2013; Schuit et al., 2013; Olofsson et al., 2014) on five RCTs (Westgate et al., 1993; Amer-Wåhlin et al., 2001; Ojala et …
Read moreKnowledge of fetal physiology is necessary to adequately interpret and deal with the findings on the CTG.
CTG was introduced 45 years ago as a screening tool to predict fetal hypoxia and enable obstetricians and midwives to analyse the changes of the fetal heart rate during labour to avoid intrapartum hypoxic – ischaemic injury. There has not been an improvement in the rate of cerebral palsy and perinatal deaths, however a significant increase in caesarean section and operative deliveries rate has been noted. CTG has a 60% false-positive rate and present guidelines encourage the visual interpretation of CTG based on “pattern recognition”, which has a high intra-observer variability. Knowledge of fetal physiology is necessary to adequately interpret and deal with the findings on the CTG.
Read moreBigger is not always better… The validity of the US randomized trial of STAN for Norway
The Norwegian reference group of fetal monitoring have made a statement regarding the US randomized trial. Please take part of their statement and recommendations!
Link to the Norwegian statement
Bigger is not always better…
The validity of the US randomized trial of STAN for Norway
Summary
The results of the US randomized trial cannot be transferred to Norwegian/European standards:
– Selection of a low-risk population (see paragraph 1)
– Other guidelines for both CTG and ST Analysis (see paragraph …